by John Moore III | June 15, 2020
Since early March, next-generation healthcare analytics reveal that people are postponing medical appointments and everything from knee replacements to colonoscopies. In fact, diagnosis of heart disease is down 37%, cancer diagnoses are down 35%, and stroke-related diagnoses are down 38%. Unfortunately, this is unlikely the result of Americans’ improved health
by Jody Ranck | June 08, 2020
What Comes Next for AI in Healthcare? View webinar recording and download the slides here: The Essentials of Health AI in a Post-Pandemic World - Webinar and Slides. As leaders of health plans and self-insured companies, you may be faced with critical decisions on how to start the post-pandemic recovery
by Jody Ranck | April 13, 2020
As the COVID-19 pandemic continues to spread across the US there are emerging patterns for the disease burden coming to light. African-American and Latinx populations are suffering a disproportionate amount of the disease burden and deaths. It is often said that pandemics are a window into society and amplify health
by John Moore III | April 01, 2020
Join Senior Analyst and report author Jody Ranck for a presentation of the key findings from Chilmark Research's latest report, The Promise of AI and ML in Healthcare: Opportunities, Challenges, and Vendor Landscape. In this webinar, Jody discusses trends across applications of artificial intelligence and machine learning in healthcare, including: business
by Hannah Ehnle | March 13, 2020
Even with HIMSS'20 canceled, the Chilmark team still wants to share our insights and guidance on the health IT market! In this webinar, each analyst presents an overview of the market trends they are following and what they are most excited about when looking ahead. They also discuss some preliminary
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. The FDA was criticized for not basing their first draft regulation criteria on use-case risk. Since then the International Medical Device Regulators Forum (IMDRF), which the FDA chaired, created a
by Chilmark Team | December 19, 2019
As we rapidly approach the end of the year it is time once again to look forward to a new year, a new decade. While we will not yet forecast out through the decade ahead (still pondering that), below is our collective look at the health IT market and what
by Chilmark Team | December 04, 2019
We must have hit a batter’s slump in 2019. In past years, our predictions of what is to come have resulted in well over a .500 batting average. In 2019 we fell to a paltry .385, which is considered a great batting average in baseball, but not so great for
